Institutional investors purchased a net $274.9 thousand shares of RGLS during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 60.24% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 1.5 Million shares of Regulus Therapeutics Inc